Vivos Therapeutics Cash Flow Statement (2020-2026) | VVOS

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-4.04M	-5.45M	12.91M	-5.33M	-6.99M	-5.43M	17.86M	-1.70M	-5.53M	-2.09M	-4.26M	-3.76M	-1.93M	-2.62M	-2.83M	-3.86M	-5.01M	-5.40M	-6.95M	-7.75M
Depreciation and Depletion (Quarter)	0.08M	0.10M	0.10M	0.20M	0.20M	0.20M	0.30M	0.20M	0.10M	0.10M	0.20M	0.10M	0.10M	0.10M	0.10M	0.20M	0.30M	0.40M	-0.20M	0.30M
Share-based Compensation (Quarter)																				0.15M
Gains from Investment Securities (Quarter)																				287.00
Asset Writedowns and Impairment (Quarter)										0.15M
Non-cash Items (Quarter)																				0.17M
Cash from Operations (Quarter)																				-6.01M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)																				0.45M
Amortization of Deferred Charges (Quarter)																				0.14M
Change in Working Capital
Change in Receivables (Quarter)																				0.19M
Change in Account Payables (Quarter)																				0.32M
Change in Accured Expenses (Quarter)																				0.12M
Other Working Capital Changes (Quarter)																				0.02M
Investing Activities
Capital Expenditures (Quarter)																				0.02M
Change in Acquisitions & Divestments (Quarter)		0.01M
Cash from Investing Activities (Quarter)																				-0.02M
Financing Activities
Other financing activities (Quarter)																				0.49M
Cash from Financing Activities (Quarter)																				6.11M
Additional items
Change in Cash (Quarter)																				0.08M
Free Cash Flow (Quarter)																				-6.03M
Net Cash Flow (Quarter)																				0.08M